BioSpace News Archive

Eisai Inc. and Purdue Pharma L.P. announced that Eisai will buy out Purdue’s rights to the worldwide collaboration for the development and commercialization of lemborexant, an investigational sleep-wake regulation agent being studied for the treatment of multiple sleep-wake disorders, including insomnia and irregular sleep-wake rhythm disorder (ISWRD) in patients with Alzheimer’s Disease.

MedX Health Corp. announced its results for the year ended December 31, 2018, which are also available on SEDAR.

It’s time to start talking ticks. Spring signals a particularly active time for ticks, just when gardeners get antsy to get their hands dirty, working in their gardens.

MHK, formerly MedHOK – Medical House of Knowledge, part of the Hearst Health network, and a Tampa-based healthcare technology pioneer that helps health plans and other managed care providers deliver better member care by bringing all critical member data together into an integrated platform, announced today the introduction of MHK CareProminence™ SELECT Appeals & Grievances Suite for small health plans

Beginning in early 2020, Novo Nordisk’s global production will be completely powered by renewable electricity, with a ten-year goal of achieving zero carbon emissions from operations and transportation.

Dr. Jaspinder Komal, Chief Veterinary Officer, World Organisation for Animal Health (OIE) Delegate for Canada / Vice President, Science Branch, Canadian Food Inspection Agency (CFIA), and Dr. Jack Shere, Chief Veterinary Officer, U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), USA will jointly present a statement on the outcomes and next steps coming out of the African Swine Fever Forum held in Ottawa.

Officials from Health Canada will hold a technical briefing to provide information on the final publication of the Tobacco Products Regulations.

Winning Entry Seeks to Rid Blood of Difficult to Remove Protein-Bound Toxins

Amylyx Pharmaceuticals, a clinical-stage pharmaceutical company developing a novel therapeutic for ALS, Alzheimer’s disease and other neurodegenerative diseases, just appointed Dr. Patrick Yeramian as Chief Medical Officer and Tom Holmes as Global Head, Supply Chain.

The possible contraction of HIV by 2 people after receiving an improperly done procedure falsely advertised as a Vampire Facial® necessitates repeating a very important warning